Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
myo-inositol + l-tyrosine + chromium picolinate + selenium + folic acid
- Development stage
- Unknown
- Lead developer
- Pharmarte
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
This combination product is a nutritional supplement formulation containing myo-inositol (2g), L-tyrosine (0.5mg), chromium picolinate (40mcg), selenium (55mcg), and folic acid (0.2mg). It is primarily investigated for the treatment of polycystic ovary syndrome (PCOS), particularly across various phenotypes. The formulation acts as an insulin sensitizer and targets hormonal regulation, including thyroid-stimulating hormone (TSH) and follicle-stimulating hormone (FSH) signaling pathways. Clinical evidence, including studies conducted at Altamedica Reproductive Medicine (NCT03673995), suggests that the synergistic action of these components helps restore menstrual regularity, improve ovulation, and reduce hyperandrogenism and BMI in affected patients.
- Other names
- myo-inositol + l-tyrosine + chromium picolinate + selenium + folic acid
02
Targets
INSR (Insulin receptor)TSH (Thyroid-stimulating hormone)
Beyond the preview
Go deeper on myo-inositol + l-tyrosine + chromium picolinate + selenium + folic acid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on myo-inositol + l-tyrosine + chromium picolinate + selenium + folic acid.